The Skin Institute to Be Established in Nice
In a press release, the CHU of Nice and Eurobiomed announced the selection of the first Experimental Skin Health Hub, a project funded by the French government as part of the Digital Health Acceleration Strategy under the France 2030 plan. This hub, focused on dermatological diseases, benefits from a total budget of €63 million over […]
The Métropole Nice Côte d’Azur Propels Its Startups to CES Las Vegas 2025
Four Metropolitan Startups at CES 2025: DataGreen, Epseed, Ovi, and Parentalis showcase the technological excellence of the Métropole Nice Côte d’Azur. Future Technologies: These companies stand out in key sectors, from sustainable data center management to secure remote work, eco-friendly hydration, and child health. Strategic Support: The Métropole Nice Côte d’Azur, the Région SUD, and […]
Virbac announces changes in its executive management
Key Highlights: Sébastien Huron (on the right) is leaving his position as Executive Managing Director at Virbac. Habib Ramdani (on the left), currently Deputy Managing Director and Group Financial Director, will temporarily replace him. The recruitment of a new Executive Managing Director is underway, supported by the Board of Directors. Sébastien Huron leaves the company […]
Virbac finalizes acquisition of minority stake in Globion, Indian poultry vaccine specialist.
Based in the Nice Côte d’Azur Metropolis, Virbac is a major player in the field of animal health. In 2023, the company celebrated 30 years of presence in the Asia-Pacific region and 40 years of operations in Spain, announcing several strategic developments. Including the creation of a subsidiary in Ireland and the acquisition of its […]
Christophe Mossé appointed as CEO of Arkopharma group
Key Points Christophe Mossé appointed as CEO of Arkopharma group He will oversee Arkopharma’s activities and related activities of Dermapharm Group. Brings industry expertise from leading groups: Naos, Galderma, Novartis,… Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements. Arkopharma, a European leader in […]
Nucleate France UniCA strengthens the ties between research, industry, and entrepreneurship in life sciences.
The opening of a Nucleate branch in Nice is an incredible opportunity for our territory. This international program, initiated by students from Harvard Medical School and present in a dozen countries, is opening a branch in France, under the direction of Sophie Demolombe, Research Director at CNRS and co-director of the University Graduate School of […]
Team Nice Côte d’Azur in force at Viva Tech 2024
Viva Tech 2024: the must-attend tech event for startups will take place from May 22 to 25 in Paris. 7 gems from the Nice Côte d’Azur metropolis have been selected to present their innovations at the South Region stand (Hall 1 – Stand B30). The Team Nice Côte d’Azur team will participate in this global […]
New urban health trail in Nice
Inauguration of a new urban health trail in Nice Fabron, strengthening Nice’s commitment to sport and health. The Acti’Santé Nice Fabron loop combines walking, physical exercises, and discovery of the botanical heritage over 2.8 kilometers. The City of Nice Sports-Health House supports this initiative aimed at promoting physical activity for all. Nice continues to demonstrate […]
Quantum Genomics is now the sole holder of all the shares and voting rights of Exactcure
In a press release on April 25, 2024, Quantum Genomics announces that it has obtained the approval of the General Meeting of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of the shares of ExactCure. The company Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC) announces that, […]
Caranx Medical Innovates in Robotic-Assisted Heart Valve Implantation
Key Points World First: Nice-based Caranx Medical successfully performs robotic-assisted heart valve implantation on an animal. Potential Impact on Cardiology: The technology could simplify complex procedures, increasing precision and safety. Promising Future: The approach could be tested on humans as early as 2025, redefining cardiac interventions. Supported by a high-level team of executives and experts […]
